KATHRYN GUIDONE: Open Payments
NPI 1427784693 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 29 payments from 5 companies in 2025. Trend: 2023 $501 · 2024 $408 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $491 |
| Lilly USA, LLC | 5 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
| Corcept Therapeutics | 3 | $65 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: Wegovy, MOUNJARO, JARDIANCE, Korlym, Ozempic, CONTRAVE.
Industry payments across NY — which companies pay providers there.
